US Patent Issued to ANAVEX LIFE SCIENCES on June 2 for "ANAVEX2-73 for the treatment of genetic neurodevelopmental disorders" (New York Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,784, issued on June 2, was assigned to ANAVEX LIFE SCIENCES CORP. (New York).

"ANAVEX2-73 for the treatment of genetic neurodevelopmental disorders" was invented by Christopher U. Missling (New York) and Alani Selvey (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides methods for treating a genetic neurodevelopmental disorder such as Rett syndrome, comprising administering to a subject in need thereof a liquid oral dosage formulation comprising a therapeutically effective amount of ANAVEX2-73."

The patent was filed on July 22, 2020, under Application No. 17/629,321.

*For further information, including images, cha...